AnPac Bio-Medical Science Co Operating Income

The latest operating income for ANPC is $-100M as of December 2022. That compares with $-110M in the prior-year period — up 6.5% year over year. Investors often review this figure alongside AnPac Bio-Medical Science Co's historical trend and sector peers before judging valuation or financial health.

Over the past year, ANPC's operating income moved from $-110M to $-100M — a 6.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in AnPac Bio-Medical Science Co's operating scale or balance-sheet position.

A operating income figure of $-100M for ANPC is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting ANPC's operating income ($-100M), review year-over-year change from $-110M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack AnPac Bio-Medical Science Co's operating income against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.